Font Size: A A A

Lung Cancer Screening: The Importance of Patient-Provider Discussions

Fewer than 10% of patients say they’ve discussed lung cancer screening with their healthcare providers.

Lung cancer remains the leading cause of cancer-related deaths in the United States, often detected at advanced stages when treatment options are limited. However, there's hope in the form of low-dose CT (LDCT) scans, which can detect lung cancer earlier, when it’s easier to treat. The screening has the potential to significantly reduce lung cancer deaths. 

CELL Series: The Future of Cancer Care: Innovative Oncology Advancements and Their Clinical Implications

This webinar will provide an overview of the Renown Health Office of Clinical Research and its oncology portfolio, offering participants insights into ongoing efforts to advance cancer care. Attendees will explore current trends in oncology treatment, focusing on how recent research findings are being applied to improve patient outcomes. The session will also examine future opportunities in cancer treatment, highlighting emerging innovations and their potential impact.